ANNA GRUBENHOFF: Open Payments
NPI 1144501057 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 61 payments from 12 companies in 2025. Trend: 2023 $723 · 2024 $670 · 2025 $1,180
Food & beverage: $1,171Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $527 |
| Novartis Pharmaceuticals Corporation | 6 | $151 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Incyte Corporation | 3 | $79 |
| Janssen Biotech, Inc. | 2 | $50 |
| Galderma Laboratories, L.P. | 3 | $50 |
| Lilly USA, LLC | 2 | $48 |
| PFIZER INC. | 2 | $47 |
| GENZYME CORPORATION | 2 | $43 |
| Almirall LLC | 1 | $38 |
Products named: SKYRIZI, RINVOQ, COSENTYX, DUPIXENT, OPZELURA, TREMFYA, NEMLUVIO, TALTZ.
Industry payments across OH — which companies pay providers there.
